SIMCERE PHARMA (02096) spent HKD 10.7033 million on September 9 to repurchase 929,000 shares.
Siheng Pharmaceutical (02096) announced that on September 9, 2026, the company spent HKD 10.7033 million to repurchase 929,000 shares.
SIMCERE PHARMA (02096) announced that on September 9, 2026, the company spent HKD 10.7033 million to repurchase 929,000 shares.
Related Articles
BOAN BIOTECH (06955) spent HKD 2.922 million on September 9 to repurchase 1 million shares.
DINGDANG HEALTH (09886) invested HK$336,300 to repurchase 420,000 shares on September 9.
Shanghai Supezet Engineering Technology Corp., Ltd. (688121.SH): Preliminary investigation reveals that some annual financial information is suspected of false recording, which may involve circumstances of significant legal violations leading to mandatory delisting.
BOAN BIOTECH (06955) spent HKD 2.922 million on September 9 to repurchase 1 million shares.
DINGDANG HEALTH (09886) invested HK$336,300 to repurchase 420,000 shares on September 9.
Shanghai Supezet Engineering Technology Corp., Ltd. (688121.SH): Preliminary investigation reveals that some annual financial information is suspected of false recording, which may involve circumstances of significant legal violations leading to mandatory delisting.
RECOMMEND
